TD Cowen reaffirmed a buy rating on Tectonic Therapeutic (TECX) on October 13, 2026.
2 reports, 2 independent
Updated Oct 19
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen reaffirmed a buy rating on Tectonic Therapeutic (TECX) on October 13, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
Related events
- TD Cowen reiterated a buy rating on MBX Biosciences shares, and Citigroup restated an outperform rating on the company.
- TD Cowen reiterated its buy rating on ExlService Holdings, Inc. shares.
- TD Cowen upgraded the stock rating for Monte Rosa Therapeutics.
- TD Cowen raised its price target and issued a buy rating for Globe Life.
- TD Cowen reaffirmed a Buy rating for Chipotle Mexican Grill stock.